Israel has gained an international reputation for speeding up the vaccination. Among the factors cited for its success is the fact that it has an organized and digital health care system, to which all citizens are registered by law.
National health minister Yuli Edelstein also says that because the health system is capable of collecting data, it was easy for Israel to make early contracts for vaccines, because drug companies knew they could get information reliable feedback about their results.
However, while the vaccination efforts could be a stimulus for Prime Minister Benjamin Netanyahu – who is seeking re – election in March despite being tested on corruption charges – a direct comparison is not easy. to do with the performance of other countries.
Countries of a larger geographical size – Israel about the same size as Wales – face more challenges in delivering vaccines to remote populations. And countries with less developed infrastructure are not suitable for the Pfizer-BioNTech vaccine, which needs to be stored in freezers at minus 70C. Israel has subdivided shipments of the Pfizer vaccine, allowing it to be sent to remote areas.
Also playing a part is the extent to which the public accepts the vaccine in the first place. Leaders of Israel’s ultra-rectangular Jewish community, which has been hit particularly hard by the virus, have issued religious rule in support, saying the threat posed by the virus overwhelms me -any other comments.
But in other countries – including Western countries such as France – public confidence in the vaccination program is far lower than officials had hoped. In a 15-country poll conducted by Ipsos Global Advisor, only 40 per cent of French respondents said they would be willing to be vaccinated. That compares with 80 per cent in China, 77 per cent in the UK, and 69 per cent in the US.